Trainee (International Collaboration)

Selection procedure reference: EMA/TR/10884 

Deadline for applications: 6 May 2025 23:59 CET 

 

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.

 

This traineeship opportunity is now open for applications until 6 May 2025 23:59 CET, with an intake on 1 October 2025.

About the traineeship programme

The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.

Placement description

We are looking for a trainee in the Regulatory Science and Innovation Task Force.

Specific objectives and projects

EMA is a member of the Drug Shortages Global Regulatory Working Group, an international forum of medicine regulators and the World Health Organization.

The group shares information about shortages of medicines with a global impact and the actions taken in each jurisdiction to prevent, monitor and mitigate the impacts of these shortages. In addition, relevant policy measures and best practices to address shortages are discussed.

 

The selected trainee will be involved in a project that will focus on the establishment of a best practice document on global drug shortage mitigation strategies. Therefore the trainee will engage with European Union/European Economic Area authorities and international regulatory authorities, and gather, analyse and compile relevant information. To inform the best practice document, the trainee will support a drug utilsation study. Relevant activities will include the analysis of study results and further integration of other relevant information, e.g. shortages data. The trainee will present results to the Global Regulatory Working Group and other relevant fora.

Learning outcomes

During this traineeship, you will acquire knowledge of:

 

• activities of the European Medicines Agency, the European Medicines Regulatory Network and on international cooperation in the context of shortages of medicinal products. 
• In addition, an understanding of activities related to the prevention and mitigation of shortages in the EU/EEA and internatioannly will be gained. Through the participation in meetings with international regulatory agencies and european regulatory agencies for mediciinal products the trainee will aquire knowledge in international and european relations.

Eligibility criteria

To be eligible for consideration for this placement, you are required to:

1. enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
2. possess a university degree in Health related Sciences (minimum of three years or more) that must have been obtained between 6 May 2024 and 6 May 2025 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
3. a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.

Additional skills

In addition to the eligibility criteria, it will be an advantage to have:

• Training in or knowledge of the EU or international regulatory framework for pharmaceuticals; Experience in scientific writing

Behavioural Competencies

You will demonstrate the followin